90491 ⎘
Indexing scheme relating to specific properties of organic compounds Optical isomers
CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE
#302KINASE INHIBITOR
#303A NOVEL PROCESS FOR THE PREPARATION OF TAPENTADOL
#304Synthesis of tipifarnib
#305Chiral N-substituted allylic amine compounds
#306Phenylalanine small organic compounds to directly modulate PCSK9 protein activity
#307Hepatitis B antiviral agents
#308METHOD FOR SEPARATION OF METHIONINE SULFOXIDE DIASTEREOMERS
#309Cyclic di-nucleotide compounds as sting agonists
#310Illudin analogs, uses thereof, and methods for synthesizing the same
#311OXIDATION OF METHYL-SUBSTITUTED BIPHENYL COMPOUNDS
#312NEW CHEMICAL COMPOUND CONTAINING ACTIVE ENANTIOMETER S-(-) KETOROLAC TROMETHAMINE FOR THE TREATMENT OF PAIN
#313Method For Preparing Hexahydrofuro-Furanol Derivative, Intermediate Thereof And Preparation Method Thereof
#314Preparation method for S-indoxacarb
#315Phenyl derivatives as cannabinoid receptor 2 agonists
#316Chiral resolution method mimicking magnetic beneficiation and the magnetic nano-inhibitors for selective enrichment
#317COMPOSITIONS AND METHODS FOR TREATING CANCER
#318NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING PROTEINOPATHIES COMPRING THE SAME
#319Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide
#320Method of preparation of (1R,3S)-3-amino-1-cyclopentanol and salt thereof
#321COMPOUNDS AND SYNTHETIC METHODS FOR THE PREPARATION OF RETINOID X RECEPTOR-SPECIFIC RETINOIDS
#322Processes for making, and methods of using, glycopyrronium compounds
#323PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES
#324Asymmetric synthesis of alpha-branched chiral amines
#325OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS
#326Pharmaceutical compounds
#327Intermediates for optically active piperidine derivatives and preparation methods thereof
#328Pharmaceutical compounds
#329Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity
#330Chiral binuclear metal complexes for stereoselective hydrolysis of saccharides and glycosides
#331METHODS OF SUSTAINING DIETARY KETOSIS AND ITS EFFECTS ON LIPID PROFILE
#332DIARYL MACROCYCLE POLYMORPH
#333Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
#334COFORMER SALTS OF (2S,3S)-METHYL 7-FLUORO-2-(4-FLUOROPHENYL)-3-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-4-OXO-1,2,3,4-TETRAHYDROQUINOLINE-5-CARBOXYLATE AND METHODS OF PREPARING THEM
#335Oxidation catalysts
#336Process for preparing chiral 2,3-dihydrothiazolo[3,2-A] pyrimidin-4-ium compounds
#337Halogenated derivatives of morphinans and uses thereof
#338Pd(II)-catalyzed enantioselective C—H arylation of free carboxylic acids
#339Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
#340Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists
#341HPK1 antagonists and uses thereof
#342Method for the production of lumateperone and its salts
#343Acryloyl-containing nuclear transport regulators and uses thereof
#344TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
#345Solid form of (-)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst
#346Anti-influenza virus pyrimidine derivative
#347MODIFIED CYCLIC DINUCLEOTIDE COMPOUNDS
#348SUBSTITUTED DIAZAHETERO-BICYCLIC COMPOUNDS AND THEIR USE
#349Covalent inhibitors of KRAS
#350Substituted dihydrobenzoxazinones, dihydroquinolones, and methods of their use and synthesis
#351(S)-CSA Salt Of S-Ketamine, (R)-CSA Salt Of S-Ketamine And Processes For The Preparation Of S-Ketamine
#352(+)-2-[1-(3-Ethoxy-4- methoxyphenyl)-2-methylsulfonylethyl]- 4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
#353Inhibitors of lysine gingipain
#354Diastereoselective synthesis of phosphate derivatives
#355Method for preparing hexahydrofuro-furanol derivative, intermediate thereof and preparation method thereof
#356Antibacterial agents: soluble salts and aqueous formulations of pyronins
#357Antibacterial agents: O-alkyl-deuterated pyronins
#358Process for the preparation of enantiomerically and diastereomerically enriched cyclobutane amines and amides
#359Prodrugs of fencamfamine
#3603-phenyl-4-hexynoic acid derivatives as GPR40 agonists
#361Process for producing 1,3-butanediol and for optionally further producing (R)-3-hydroxybutyl (R)-3-hydroxybutyrate
#362Tertiary alcohols as PI3K-γ inhibitors
#363Piperidine CXCR7 receptor modulators
#364Process for preparing intermediates for the synthesis of optically active beta-amino alcohols by enzymatic reduction and novel synthesis intermediates
#365Compounds for modulating mitochondrial function
#366Methods of making deuterium-enriched N-acetylcysteine amide (d-NACA) and (2R, 2R′)-3,3′-disulfanediyl bis(2-acetamidopropanamide) (diNACA) and using d-NACA and diNACA to treat diseases involving oxidative stress
#367CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE
#368Optically active substituted 2,3-bisphosphinoquinoxalines and processes for producing the same
#369MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#370Method for preparing pimavanserin and tartrate thereof by using triphosgene
#371Methods of synthesis of (1R,2R,5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
#372Atmospheric moisture harvester
#373ENANTIOSELECTIVE DESTRUCTION OF CHIRAL MOLECULES
#374USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN
#375Coordinative alignment of molecules in chiral metal-organic frameworks
#376Process for the preparation of droxidopa and its intermediate
#377Synthesis of desosamines
#378Compositions and methods for treating and preventing neurodegenerative disorders
#379Process for preparing an aromatic polyamine mixture
#380Fruity odorant
#381Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio
#382Phenylpropionate compound, preparation method for same, and applications thereof
#383P2X7 modulators
#384Method for producing lactic acid and method for producing polylactic acid
#385Oxidation of Methyl-substituted Biphenyl Compounds
#386Derivatives of sobetirome
#387Synthesis and use of oxa-spirodiphosphine ligand
#388Epoxy compound, curable composition containing the same, and cured product obtained by curing curable composition
#389Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#390Substituted quinazoline compound having blood-brain barrier penetration capability
#391Preparation of acetate compounds via a ketene compound
#392Synthesis and application of chiral substituted polyvinylpyrrolidinones
#393Methods of using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
#394SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,1'-BIPHENYL COMPOUNDS
#395Substituted indoline derivatives as dengue viral replication inhibitors
#396Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide
#397KDM1A inhibitors for the treatment of disease
#398SOLID STATE FORMS OF TRISODIUM VALSARTAN: SACUBITRIL
#399Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex
#400Ethynyl derivatives
#401Phenylpiperazine proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators and their use
#402CDK2 inhibitors
#403Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease
#404Intermediate compound of novel tetrahydronaphthyl urea derivative
#405Heterocyclic compounds as modulators of mGluR7
#406Cyanopyrrolidines as dub inhibitors for the treatment of cancer
#407Hepatitis B antiviral agents
#4083-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative and method for synthesizing optical isomer thereof
#409Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
#410Salts of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
#411Phosphoramidate compound and preparation method and crystal thereof
#412Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids
#413Process for the preparation of deuterated ethanol from D2
#414N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
#415Derivatives of sobetirome
#416Substituted indoline derivatives as dengue viral replication inhibitors
#417FLUORINATED AMIDE DERIVATIVES AND THEIR USES AS THERAPEUTIC AGENTS
#418Reagents for quantitative mass spectrometry
#419Alcohol derivatives as KV7 potassium channel openers
#420Substituted Phenethylamines with Serotoninergic and/or Norepinephrinergic Activity
#421METHODS AND DEVICES FOR USING ISOPERILLYL ALCOHOL
#422Polyfluoro-substituted aromatic heterocyclic derivative, pharmaceutical composition containing same, and applications thereof
#423Process for the preparation of deuterated ethanol from DO
#424Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
#425Process for converting S-enantiomer to its racemic form
#426Enantioselective synthesis of α-quaternary Mannich adducts by palladium-catalyzed allylic alkylation
#427Method for separating optically active hydroxy cineole derivatives
#428Enantiomerically purified GPER agonist for use in treating disease states and conditions
#429S-enantiomers of beta-hydroxybutyrate and butanediol and methods for using same
#430Process for the separation of optical isomers of racemic 3-alkylpiperidine-carboxylic acid ethyl esters
#431Methods and intermediates for synthesizing SK1-I
#432Pharmaceutical compositions comprising monoterpenes
#433Synthetic route to 2′-deoxy-2′,2′-difluorotetrahydrouridines
#434Anti-inflammatory composition including novel kaempferol-based compound derived from post-fermented tea
#435Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS
#436DIFLUOROALKYLCYCLOPROPYL AMINO ACIDS AND ESTERS, AND SYNTHESES THEREOF
#437CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE
#438Chemoselective methylene hydroxylation in aromatic molecules
#439Method of preparing (3R,4S)-3-acetamido-4-allyl-n-(tert-butyl)pyrrolidine-3-carboxamide
#440Processes for the preparation of pyrimidinylcyclopentane compounds
#441Substituted benzoimidazoles as modulators of ROR-γ
#442LACTAM COMPOSTIONS
#443Compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders
#444N-(7-fluoro-1,1,3-trimethyl -1 H-inden-4yl) amides and a process for preparing same
#445Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2.3-f]chromene derivative and optical isomer of thereof
#446Solid state forms of valbenazine
#447Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols
#448CRYSTALLINE DIACYLHYDRAZINE AND THE USE THEREOF
#449Short-acting benzodiazepine salts and their polymorphic forms
#450ANTIFIBRINOLYTIC COMPOUNDS
#451Process for the preparation of boronic acid esters
#452ENANTIOMERICALLY PURIFIED GPER ANGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS
#453Method for producing optically active pyrrolidine compounds
#454Antifungal compound process
#455CRYSTALLINE SALTS OF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME
#456Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes
#457AMPK-activating heterocyclic compounds and methods for using the same
#458Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds
#459CHIRAL SEPARATION AND ANALYSIS BY MOLECULAR PROPELLER EFFECT
#460Porous chiral materials and uses thereof
#461Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
#462Imidazopyridazine compound
#463Pharmaceutical compounds
#464Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone
#465PICOLINAMIDES WITH FUNGICIDAL ACTIVITY
#466Compounds for modulating mitochondrial function
#467Halogenated compound and axially chiral isomer thereof
#468Tetrahydronaphthyl urea derivative
#469Glucagon antagonists
#470Inhibitors of lysine gingipain
#471Pd(II)-catalyzed enantioselective β-methylene C(sp)—H bond activation
#472Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof
#473Process and intermediates
#474Thionyl tetrafluoride modified compounds and uses
#475Medicinal use of serrulatane diterpenes
#476Pesticidal and parasiticidal vinyl isoxazoline compounds
#477CHIRAL RESOLUTION OF AN INTERMEDIATE OF SUVOREXANT AND COCRYSTALS THEREOF
#478Picolinamides as fungicides
#479SYNTHESIS OF ARYL CYCLOHEXANE ESTER DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS
#480Glucosylceramide synthase inhibitors for the treatment of diseases
#481Crystalline forms of neurotrophin mimetic compounds and their salts
#482Crystalline metal organic framework
#483Method of preparing ezetimibe and intermediate thereof
#484Alcohol derivatives of carboxamides as Kv7 potassium channel openers
#485Fluorohydroxyproline derivatives useful in the preparation of proteolysis targeted chimeras
#4862,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptor
#487Method for the separation of enantiomeric mixtures from metal complexes
#488Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer
#489Selective bromodomain inhibition of fungal Bdf1
#490DIARYL MACROCYCLE POLYMORPH
#491Surface active ionic liquid with activity in aqueous and non-aqueous media
#492Method of producing proton pump inhibitor compound having optical activity
#493Nahlsgen optical resolution method
#494Vinylogous phenethylamines as neurotransmitter releasers
#495Method for the preparation of (S)-2-acetyloxypropionic acid and derivatives thereof
#496Processes for the preparation of sofosbuvir and intermediates thereof
#497Crystal forms and salt forms of 7h-pyrrolo[2,3-d]pyrimidine compounds and preparation method thereof
#498Myricanol Derivatives and Uses Thereof for Treatment of Neurodegenerative Diseases
#499PEGYLATED RESOLVING AGENTS FOR IMPROVED RESOLUTION OF RACEMIC MIXTURE
#500P-chiral phosphine ligands and use thereof for asymmetric synthesis
#501Mild and efficient preparation method for α-acyloxyenamide compounds and use thereof in synthesis of amide and polypeptide
#502Derivatives of sobetirome
#503Processes and intermediates for NEP inhibitor synthesis
#504α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof
#505Antifungal compound process
#506Compositions and methods for treating cancer
#507METHOD FOR PRODUCING CHIRAL AMINONITRILES
#508BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF
#509Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
#510Imidazopyridine derivatives and the use thereof as medicament
#511Coordinative alignment of molecules in chiral metal-organic frameworks
#512Vasopressin receptor antagonists and products and methods related thereto
#513Piperdine CXCR7 receptor modulators
#514Epoxy compound, curable composition containing the same, and cured product obtained by curing curable composition
#515Processes for making, and methods of using, glycopyrronium compounds
#516Process for preparing acylated amphetamine derivatives
#517Dithioamine reducing agents
#518OPTICALLY ACTIVE PYRANOCHROMENYL PHENOL DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#519Tertiary alcohols as PI3K-γ inhibitors
#520Methods of synthesis of (1R, 2R, 5R)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein
#521Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids
#522Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses
#523CONFIGURATIONAL STEREOISOMER OF DIFETHIALONE, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS
#524ETHYNYL DERIVATIVES
#525Carbocyclic compounds as ROR gamma modulators
#526Solid form of (−)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst
#527Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same
#528Method of synthesizing prothioconazole and optically active isomers thereof and intermediates
#529Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols
#530Methods of Making Deuterium-Enriched N-acetylcysteine Amide (D-NACA) and (2R, 2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) and Using D-NACA and DINACA to Treat Diseases Involving Oxidative Stress
#531Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof
#532METHOD FOR PREPARING D-4,4'-BIPHENYLALANINE ALKYL ESTER OR L-4,4'-BIPHENYLALANINE ALKYL ESTER FROM DL-4,4'-BIPHENYLALANINE ALKYL ESTER
#533Polycyclic carbogenic molecules and uses thereof as anti-cancer agents
#534TERTIARY AMIDES AND METHOD OF USE
#535Substituted indoline derivatives as dengue viral replication inhibitors
#536Chiral N-substituted allylic amine compounds
#537COFORMER SALTS OF (2S,3S)-METHYL 7-FLUORO-2-(4-FLUOROPHENYL)-3-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-4-OXO-1,2,3,4-TETRAHYDROQUINOLINE-5-CARBOXYLATE AND METHODS OF PREPARING THEM
#538Process for preparing pleuromutilin
#539Bromotriazole intermediates
#540Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof
#541P2X7 modulators
#542Process for converting S-enantiomer to its racemic form
#543Hepatitis B antiviral agents
#544Method for preparation of N-acetyl cysteine amide and derivatives thereof
#545Homogeneous polysaccharide with immunoregulation activity and preparation method thereof
#546Fruity odorant
#547Methods and materials for the production of monomers for nylon-4/polyester production
#548Process for the separation of enantiomers of piperazine derivatives
#549Covalent inhibitors of KRAS
#550Process for the preparation of optically active Beraprost
#551Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride
#552Pyrrolopyrimidine compounds and uses thereof
#553OPTICALLY ACTIVE 2-HYDROXY TETRAHYDROTHIENOPYRIDINE DERIVATIVES, PREPARATION METHOD AND USE IN MANUFACTURE OF MEDICAMENT THEREOF
#554Process for electrochemical separation of enantiomers of an amino acid from a racemic mixture
#555Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
#556CRYSTALLINE SALTS OF (4S,4AS,5AR,12AS)-4-DIMETHYLAMINO-3,10,12,12A-TETRAHYDROXY-7-[(METHOXY(METHYL)AMINO)-METHYL]-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE AND METHODS OF USING THE SAME
#557Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals
#558CHEMICAL COMPOUNDS
#559Process for preparation of prostacyclin derivatives
#560Substituted tetrahydrocarbazole and carbazole carboxamide compounds
#561Synthesis of cannabinoids
#562Tetrahydronaphthyl urea derivative
#563Prodrugs of fencamfamine
#564Configurational stereoisomer of difethialone, composition and rodenticide bait comprising same, and method for controlling target rodent pests
#565HYDROXYBUTYRATE ESTER AND MEDICAL USE THEREOF
#566LIGANDS AND CATALYSTS
#567STEREOISOMER OF FLOCOUMAFEN, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS
#568SYNTHESIS OF LEVOMETHADONE HYDROCHLORIDE OR DEXTROMETHADONE HYDROCHLORIDE AND METHODS FOR USE THEREOF
#569Methods of using (+)- 2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione
#570High stress resistant plant growth regulator and preparation method and use thereof
#571CHIRAL COMPOUNDS OF VARYING CONFORMATIONAL RIGIDITY AND METHODS OF SYNTHESIS
#572Chiral cyclodecynes and methods
#573STEREOISOMER OF FLOCOUMAFEN, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS
#574Method for preparing long-chain compound
#575Perfume ketones
#576Diastereoselective synthesis of phosphate derivatives
#577Heterocyclic compound
#578Configurational stereoisomer of difethialone, composition and rodenticidal bait comprising same, and process for controlling target rodent pests
#579STEREOISOMER OF FLOCOUMAFEN, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS
#580Configurational stereoisomer of bromadiolone, composition and rodenticide bait comprising same, and method for controlling target rodent pests
#581Composition and rodenticidal bait comprising flocoumafen, and process for controlling target rodent pests
#582STEREOISOMER OF FLOCOUMAFEN, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS
#583STEREOISOMER OF BROMADIOLONE, COMPOSITION AND RODENTICIDAL BAIT COMPRISING SAME, AND PROCESS FOR CONTROLLING TARGET RODENT PESTS
#584Method of preparing (3R,4S)-3-acetamido-4-allyl-N-(tert-butyl)pyrrolidine-3-carboxamide
#585Water-soluble L-DOPA esters
#586STEREOISOMER OF BROMADIOLONE, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS
#587Method for producing (Z)-2-benzoyloxy-12-heptadecene and (2S,12Z)-2-hydroxy-12-heptadecene and method for producing (2S,12Z)-2-acetoxy-12-heptadecene
#588SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS
#589Method for preparing D-arginine
#590Process and intermediates
#591Process for the preparation of 3-substituted cannabinoid compounds
#592Processes for the preparation of SGLT-2 inhibitors, intermediates thereof
#593Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratio
#594Inhibitors of lysine gingipain
#595Antiviral-agent resistant virus detection system
#596Surface acoustic wave sensor
#597Fluorinated amide derivatives and their uses as therapeutic agents
#598Asymmetric addition reactions
#599Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine
#600Process and novel polymorphic form of Apremilast